State MN
Clinical Trials in Minnesota
Recruiting clinical trials with at least one study location in Minnesota. Data updated daily from ClinicalTrials.gov.
Top Conditions in Minnesota
NCT06295367 N/A
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Condition
Malignant Solid Neoplasm
Enrollment
760 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07083011 Phase 2
Recruiting
A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
35 pts
Location
United States
Sponsor
Mayo Clinic
NCT05754450 Phase 3
Recruiting
An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects wit...
Condition
Leukocyte Adhesion Deficiency
Enrollment
2 pts
Location
United States
Sponsor
AUG Therapeutics
NCT06679790 N/A
Recruiting
Trajectories of Change in Tourette Syndrome
Condition
Tourette Syndrome
Enrollment
30 pts
Location
United States
Sponsor
University of Minnesota
NCT06088290 Phase 3
Recruiting
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone ...
Condition
Leiomyosarcoma
Enrollment
450 pts
Location
United States, Austria, Belgium
Sponsor
PharmaMar
NCT05394103 Phase 1, Phase 2
Recruiting
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Condition
Advanced Cancer
Enrollment
130 pts
Location
United States, South Korea
Sponsor
Qurient Co., Ltd.
NCT05611775 N/A
Recruiting
Adult Spinal Deformity Surgery Real-World Functional Activity
Condition
Degenerative Thoracolumbar Deformity
Enrollment
50 pts
Location
United States
Sponsor
Mayo Clinic
NCT00830557 N/A
Recruiting
Collecting Medical Information and Tissue Samples From Patients With Pancreatic ...
Condition
Islet Cell Tumor
Enrollment
20,000 pts
Location
United States
Sponsor
Mayo Clinic
NCT02579967 Phase 2
Recruiting
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodefi...
Condition
Primary T-cell Immunodeficiency Disorders
Enrollment
354 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05643872 Phase 3
Recruiting
A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhy...
Condition
Pachyonychia Congenita
Enrollment
45 pts
Location
United States
Sponsor
Palvella Therapeutics, Inc.
NCT05913908 N/A
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Enrollment
15 pts
Location
United States, Poland
Sponsor
CroiValve Limited
NCT04665739 Phase 2
Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive...
Condition
Advanced Lung Neuroendocrine Tumor
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03507257 N/A
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Condition
Early Onset Alzheimer Disease
Enrollment
850 pts
Location
United States, Argentina, Netherlands
Sponsor
Indiana University
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT03305835 N/A
Recruiting
Monogenic Kidney Stone - Genetic Testing
Condition
Rare Kidney Stone Diseases
Enrollment
6,000 pts
Location
United States
Sponsor
Mayo Clinic
NCT07287332 N/A
Recruiting
BLOOM: Pragmatic Feasibility Trial
Condition
Sepsis
Enrollment
300 pts
Location
United States
Sponsor
Mayo Clinic
NCT06228924 Phase 1
Recruiting
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 i...
Condition
Arrhythmogenic Right Ventricular Cardiomyopathy
Enrollment
15 pts
Location
United States
Sponsor
Tenaya Therapeutics
NCT06655896 Phase 2
Recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cu...
Condition
Scleroderma, Diffuse
Enrollment
96 pts
Location
United States, Australia, Austria
Sponsor
Novartis Pharmaceuticals
NCT03511118 N/A
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breast...
Condition
Lactating Women on Select DOI
Enrollment
1,600 pts
Location
United States, Canada
Sponsor
Duke University
NCT06118515 Phase 1
Recruiting
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cy...
Condition
Congenital Cytomegalovirus Infection
Enrollment
12 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06692920 N/A
Recruiting
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor ...
Condition
Parkinson Disease
Enrollment
25 pts
Location
United States
Sponsor
University of Minnesota
NCT05652023 N/A
Recruiting
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Condition
Bladder Dysfunction
Enrollment
2,023 pts
Location
United States
Sponsor
Mayo Clinic
NCT07325240 Phase 4
Recruiting
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and...
Condition
Open Angle Glaucoma
Enrollment
30 pts
Location
United States
Sponsor
Mayo Clinic
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan, United Kingdom
Sponsor
Stoke Therapeutics, Inc
NCT04920474 N/A
Recruiting
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation...
Condition
Autologous Stem Cell Transplantation
Enrollment
99,999,999 pts
Location
United States
Sponsor
Center for International Blood